Everest Medicines Ltd. is a biopharmaceutical company, which engages in the developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asian markets. Its therapeutic areas of interest include oncology, autoimmune disorders, cardio-renal diseases, and infectious diseases. The company was founded in July 2017 and is headquartered in Shanghai, China.